Rubius Therapeutics, Inc. EPS - Earnings per Share 2018-2022 | RUBY
Rubius Therapeutics, Inc. eps - earnings per share from 2018 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Rubius Therapeutics, Inc. Annual EPS |
| 2022 |
$-1.99 |
| 2021 |
$-2.23 |
| 2020 |
$-2.08 |
| 2019 |
$-2.08 |
| 2018 |
$-2.27 |
| 2017 |
$-5.55 |
| 2016 |
$-1.63 |
| Rubius Therapeutics, Inc. Quarterly EPS |
| 2022-12-31 |
$-0.22 |
| 2022-09-30 |
$-0.70 |
| 2022-06-30 |
$-0.49 |
| 2022-03-31 |
$-0.58 |
| 2021-12-31 |
$-0.61 |
| 2021-09-30 |
$-0.55 |
| 2021-06-30 |
$-0.56 |
| 2021-03-31 |
$-0.51 |
| 2020-12-31 |
$-0.50 |
| 2020-09-30 |
$-0.51 |
| 2020-06-30 |
$-0.47 |
| 2020-03-31 |
$-0.60 |
| 2019-12-31 |
$-0.57 |
| 2019-09-30 |
$-0.59 |
| 2019-06-30 |
$-0.50 |
| 2019-03-31 |
$-0.42 |
| 2018-12-31 |
$2.30 |
| 2018-09-30 |
$-0.42 |
| 2018-06-30 |
$-2.43 |
| 2018-03-31 |
$-1.72 |
| 2017-09-30 |
$-1.48 |
| 2017-06-30 |
$-1.25 |
